| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/09/2010 | US20100227906 C-substituted Diindolylmethane Compositions and Methods for the Treatment of Multiple Cancers |
| 09/09/2010 | US20100227896 Use of vitamin pp compounds |
| 09/09/2010 | US20100227878 Noscapine analogs and their use in treating cancers, including drug-resistant cancers |
| 09/09/2010 | US20100227877 New camptothecin derivatives and uses thereof |
| 09/09/2010 | US20100227873 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 09/09/2010 | US20100227866 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 09/09/2010 | US20100227863 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds |
| 09/09/2010 | US20100227861 IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS |
| 09/09/2010 | US20100227859 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 09/09/2010 | US20100227858 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 09/09/2010 | US20100227855 Helix 12 directed non-steroidal antiandrogens |
| 09/09/2010 | US20100227853 Inhibitors of cyclic amp phosphodiesterases |
| 09/09/2010 | US20100227849 Leukemia treatment method and composition |
| 09/09/2010 | US20100227846 Substituted pyrazole derivative |
| 09/09/2010 | US20100227838 Combination Therapy for Treating Cancer and Diagnostic Assays for Use Therein |
| 09/09/2010 | US20100227834 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 09/09/2010 | US20100227832 Modulation of telomere length in telomerase positive cells and cancer therapy |
| 09/09/2010 | US20100227831 Compositions and methods for cancer treatment |
| 09/09/2010 | US20100227828 New synergistic phytochemical composition for the treatment of obesity |
| 09/09/2010 | US20100227827 Method of increasing tryptophan and nicotinamide levels in vivo |
| 09/09/2010 | US20100227825 Peptides and peptide mimetics to treat cancer |
| 09/09/2010 | US20100227823 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 09/09/2010 | US20100227821 Monitoring and modulating hgf/hgfr activity |
| 09/09/2010 | US20100227811 Farnesylamine derivatives and methods of use |
| 09/09/2010 | US20100227808 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 09/09/2010 | US20100227804 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier |
| 09/09/2010 | US20100227798 Use of the staudinger ligation in in vivo assembly of a biologically active compound |
| 09/09/2010 | US20100227794 Smart contrast agent and method for detecting transition metal ions and treating related disorders |
| 09/09/2010 | US20100227791 Compounds Having Antitumor Activity |
| 09/09/2010 | US20100227005 Methods to treat and/or prevent mucositis |
| 09/09/2010 | US20100227002 Antioxidant compositions comprising extracts of myrtle and rosemary |
| 09/09/2010 | US20100226996 Compositions and methods of delivery of pharmacological agents |
| 09/09/2010 | US20100226987 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| 09/09/2010 | US20100226974 Antibody recognizing antigen |
| 09/09/2010 | US20100226970 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 09/09/2010 | US20100226954 Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/09/2010 | US20100226938 Cellular and viral inactivation |
| 09/09/2010 | US20100226931 Compounds for immunopotentiation |
| 09/09/2010 | US20100226923 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/09/2010 | US20100226922 Specific protease inhibitors and their use in cancer therapy |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226920 Medical delivery device for therapeutic proteins based on single domain antibodies |
| 09/09/2010 | US20100226919 Antitumoral Treatments |
| 09/09/2010 | US20100226913 Therapeutic Compositions Comprising Monoterpenes |
| 09/09/2010 | US20100226887 Beta-2-glycoprotein 1 is an inhibitor of angiogenesis |
| 09/09/2010 | US20100226881 PYRAZOLO[1,5-a]PYRIDINES AND THEIR USE IN CANCER THERAPY |
| 09/09/2010 | US20100226880 Treatment with anti-vegf antibodies |
| 09/09/2010 | US20100226878 Methods of inhibiting photoreceptor apoptosis |
| 09/09/2010 | DE202010006543U1 Erlotinibresinat Erlotinibresinat |
| 09/08/2010 | EP2226334A2 Immunoregulatory structures from normally occuring proteins |
| 09/08/2010 | EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii |
| 09/08/2010 | EP2226318A2 Dye-Azide compounds for dual photherapy |
| 09/08/2010 | EP2226315A1 2-aminoquinazoline derivative |
| 09/08/2010 | EP2226085A1 Anti-angiogenic compositions and methods of use |
| 09/08/2010 | EP2226072A1 Combinations of suberoylanilide hydroxamic acid and antimetbolic agents for treating cancer |
| 09/08/2010 | EP2225278A2 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 09/08/2010 | EP2225271A2 New non-selective somatostatin analogues |
| 09/08/2010 | EP2225262A2 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 09/08/2010 | EP2225254A1 Therapeutic cancer treatments |
| 09/08/2010 | EP2225247A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| 09/08/2010 | EP2225245A2 N-phenyl-imidazoý1,2-a¨pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/08/2010 | EP2225244A1 Imidazoý1,2-a¨pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/08/2010 | EP2225243A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazoýl,2- a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/08/2010 | EP2225242A2 Derivatives of n-heterocyclic-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/08/2010 | EP2225241A2 Derivatives of n-phenyl-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/08/2010 | EP2225240A2 Derivatives of 6-heterocyclic-imidazoýl,2-a¨pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/08/2010 | EP2225235A2 Thiazole carboxamide derivatives and their use to treat cancer |
| 09/08/2010 | EP2225226A1 Compounds and method for treatment of cancer |
| 09/08/2010 | EP2225201A2 Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide) |
| 09/08/2010 | EP2224960A2 Method of treating cancer |
| 09/08/2010 | EP2224958A2 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| 09/08/2010 | EP2224954A2 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 09/08/2010 | EP2224950A1 Medicament for the treatment of cancer of the pancreas |
| 09/08/2010 | EP2224947A1 Use of somatostatin analogs in meningioma |
| 09/08/2010 | EP2224946A1 Anti-proliferative compounds and their use |
| 09/08/2010 | EP2224938A1 Extract of piper betel leaves for the treatment of human malignancies by inducing oxidative stress |
| 09/08/2010 | EP2224925A1 Compounds for use in the treatment of cancer |
| 09/08/2010 | EP2224904A2 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 09/08/2010 | EP2224804A1 Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors |
| 09/08/2010 | EP1692183B1 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 09/08/2010 | EP1644376B1 PYRROLO 3,4-c PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS |
| 09/08/2010 | EP1611151B1 Stq-peptides |
| 09/08/2010 | EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 09/08/2010 | EP1478667B1 Anti-human tenascin monoclonal antibody |
| 09/08/2010 | EP1478624B1 Chemical compounds |
| 09/08/2010 | EP1454903B1 Thiadiazoline derivatives for treating cancer |
| 09/08/2010 | EP1429797B1 Diagnosis and treatment of malignant neoplasms |
| 09/08/2010 | EP1412374B1 Novel pgc-1 isoforms and uses therefor |
| 09/08/2010 | EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/08/2010 | EP1263759B1 Azaindoles |
| 09/08/2010 | EP1261325B1 Tumor inhibiting compositions comprising nitroacridines |
| 09/08/2010 | EP1085905B1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 09/08/2010 | CN1954839B Medical composition prepared by caulis Marsdeniae Tenacissimae, ginseng and astragalus root |
| 09/08/2010 | CN1950376B Curcumol derivatives, compositions comprising the same and use in manufacture of medicament |
| 09/08/2010 | CN1942581B Antibody with osteoclast-related protein as target |
| 09/08/2010 | CN1919874B Antibody molecule ATF-Fc fusion albumen of antiurokinase type fibrinolysin activator receptor and use thereof |
| 09/08/2010 | CN1915221B Liposome of alkaloid in vinca, and preparation method |
| 09/08/2010 | CN1908015B Stabilized small molecule polypeptide capable of inhibiting HER2 high expression tumour cell proliferation |
| 09/08/2010 | CN1842341B Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng |
| 09/08/2010 | CN1754002B Compositions concerning poxviruses and cancer and its preparation method |